2C-T-13

2C-T-13, also known as 4--2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL.

Use and effects

The dose range of 2C-T-13 is 25 to 40mg and its duration is approximately 6 to 8hours according to Alexander Shulgin. 2C-T-13 produces many closed-eye visuals and geometric patterns. It also produces slight visual distortion.

Chemistry

The drug has structural properties similar to mescaline and other drugs in the 2C-T series, with the most closely related compounds being 2C-T-7 and 2C-T-21.

History

2C-T-13 was first described in the scientific literature by Alexander Shulgin and colleagues in 1991. Subsequently, it was described in greater detail by Shulgin in his 1991 book PiHKAL.

Society and culture

Legal status

Canada

As of October 31, 2016, 2C-T-13 is a controlled substance in Canada.

United States

2C-T-13 is not scheduled in the United States, but possession and sales of 2C-T-13 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.